• Lab studies seek hormone-based obesity treatment

    Dr. James E. Blevins of the VA Puget Sound Health Care System completed the study with colleagues from Seattle Children’s Research Institute; the University of Washington; Harvard Medical School; and OXT Therapeutics, Inc. The research focused on ASK1476, a human-made peptide with a structure similar to that of oxytocin.

  • VA clinician, Army Veteran, a world leader in prostate cancer research

    I’m involved in prostate cancer basic research and new drug development. Prostate cancer is the most common non-skin cancer in Veterans. About 35,000 Veterans with prostate cancer receive treatment in the VA system.

  • COVID-19 testing: VA studying 3D-printed nasal swabs to guard against future declines in traditional swabs

    VA researchers are studying the safety and effectiveness of 3D-printed nasal swabs, in case of another urgent nationwide need to test patients for COVID-19 or other infectious diseases.

  • Study points to race, ethnicity as COVID-19 risk factors

    The research team included investigators from the VA Palo Alto Health Care System, VA Puget Sound Health Care System, VA Tennessee Valley Healthcare System, and several other research institutions, including Yale University.

  • Learn more about precision oncology for Veterans with prostate cancer

    Hear the latest on treating prostate cancer. Check out a Feb. 24 lecture, online or in person at VA headquarters, on precision oncology for Veterans.

  • VA, Prostate Cancer Foundation seek solutions for aggressive prostate cancer

    A partnership between VA and the Prostate Cancer Foundation is speeding the development of treatments and cures for Veterans with aggressive—or metastatic—prostate cancer through precision oncology.

Other ways to connect with